XTLB
XTL Biopharmaceuticals
XTLB
XTLB
5 hedge funds and large institutions have $2M invested in XTL Biopharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.
Holders
5
Holders Change
-1
Holders Change %
-16.67%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Morgan Stanley
New York
|
$216K |
Top Sellers
| 1 |
1
UBS Group
Zurich,
Switzerland
|
$0 |
| 2 |
SW
2
SteelPeak Wealth
Woodland Hills,
California
|
$47K |
| 3 |
3
Renaissance Technologies
New York
|
$148K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
NC
1
Noked Capital
Tel Aviv,
Israel
| $794K | 198,888 | – | – |
|
|
NI
2
Noked Israel
Ramat Hasharon,
Israel
| $794K | 198,888 | – | – |
|
|
3
Morgan Stanley
New York
| $216K | 54,064 | +38 | +0.1% |
|
|
4
Renaissance Technologies
New York
| $148K | 37,187 | -1,613 | -4% |
|
|
SW
5
SteelPeak Wealth
Woodland Hills,
California
| $47K | 11,671 | -2,704 | -19% |
|
|
6
UBS Group
Zurich,
Switzerland
| – | – | -3,524 | Closed |
|
|
CFGS
7
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|